Jeremy Clark
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jeremy Clark has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Colin S. Cooper
Department of Metabolic Health, Norwich Medical School, University of East Anglia, Norwich NR4 7UQ, UK
2 shared publications - Abraham Gihawi
Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, UK
1 shared publication Adrienne M. Flanagan
University College London, London WC1E 6BT, UK
1 shared publication- Alexander Rubinsteyn
Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
1 shared publication - Andrew Graeme Schache
Liverpool Head & Neck Centre Liverpool University Hospitals NHS Foundation Trust, Aintree University Hospital Liverpool UK
1 shared publication - Beatriz de la Iglesia
University of East Anglia
1 shared publication
Latest Publications
- 3 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (814) , eads6166
The landscape of microbial associations in human cancer
Oncomicrobes are estimated to cause 15% of cancers worldwide. When cancer whole-genome sequencing (WGS) data are collected, the microbes present are also sequenced, allowing the investigation of potential etiological and clinical associations. Interrogating the microbial community for 8908 patients encompassing 22 cancer types from the Genomics England WGS dataset revealed that only colorectal tumors exhibited unmistakably distinct microbial communities that can reliably be used to distinguish anatomical site [positive predictive value (PPV) = 0.95]. This pattern was validated in two independent datasets. Potential clinical relevance uncovered by our analyses included accurate detection of alphapapillomaviruses [human papillomavirus (HPV)] in oral cancers, when compared with current clinical standards, and the detection of rare, highly pathogenic viruses such as human T-lymphotropic virus–1. Biomarker investigations demonstrated statistically significant associations ( P < 0.05) between a subset of anaerobic bacteria and survival in certain subtypes of sarcoma. Our results contradict previous claims that each cancer type has a distinct microbiological signature but highlight the potential value of microbial analysis for certain cancers as WGS of tumor samples becomes common in the clinic.
- 3 September 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 17 (814) , eads6166
The landscape of microbial associations in human cancer
Oncomicrobes are estimated to cause 15% of cancers worldwide. When cancer whole-genome sequencing (WGS) data are collected, the microbes present are also sequenced, allowing the investigation of potential etiological and clinical associations. Interrogating the microbial community for 8908 patients encompassing 22 cancer types from the Genomics England WGS dataset revealed that only colorectal tumors exhibited unmistakably distinct microbial communities that can reliably be used to distinguish anatomical site [positive predictive value (PPV) = 0.95]. This pattern was validated in two independent datasets. Potential clinical relevance uncovered by our analyses included accurate detection of alphapapillomaviruses [human papillomavirus (HPV)] in oral cancers, when compared with current clinical standards, and the detection of rare, highly pathogenic viruses such as human T-lymphotropic virus–1. Biomarker investigations demonstrated statistically significant associations ( P < 0.05) between a subset of anaerobic bacteria and survival in certain subtypes of sarcoma. Our results contradict previous claims that each cancer type has a distinct microbiological signature but highlight the potential value of microbial analysis for certain cancers as WGS of tumor samples becomes common in the clinic.
- Open Access
- 10 July 2015
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 3 (3) , e26
Building Data-Driven Pathways From Routinely Collected Hospital Data: A Case Study on Prostate Cancer
Clinical informatics, decision support for health professionals, electronic health records, and ehealth infrastructures.
- 10 July 2015
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 3 (3) , e26
Open AccessBuilding Data-Driven Pathways From Routinely Collected Hospital Data: A Case Study on Prostate Cancer
Clinical informatics, decision support for health professionals, electronic health records, and ehealth infrastructures.